about
Emerging drugs and vaccines for candidemiaTopological and mutational analysis of Saccharomyces cerevisiae Fks1Natural product and natural product derived drugs in clinical trials.An evidence-based systematic review of beta-glucan by the natural standard research collaboration.Newer patents in antimycotic therapy.The novel oral glucan synthase inhibitor SCY-078 shows in vitro activity against sessile and planktonic Candida spp.Synthesis and antifungal properties of papulacandin derivatives.
P2860
Q26828993-DAA038D1-02DD-4A62-8EAE-2C31A12F47F2Q36156130-768FB106-2B7E-4AF5-8A23-10FAC10853F4Q38247457-D3D010DA-E538-4242-98AA-818910652AC1Q38264166-C1F9E474-6177-452D-B708-07537B7E25E9Q38743672-DC04A486-4E69-4DD2-A17F-AA7994F7E316Q40340923-DDDA8F63-FD39-4873-AD15-784CDFBF27EDQ42223905-D8A5CB71-68E1-4798-B809-99279F394AAD
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
New β-glucan inhibitors as antifungal drugs.
@en
New β-glucan inhibitors as antifungal drugs.
@nl
type
label
New β-glucan inhibitors as antifungal drugs.
@en
New β-glucan inhibitors as antifungal drugs.
@nl
prefLabel
New β-glucan inhibitors as antifungal drugs.
@en
New β-glucan inhibitors as antifungal drugs.
@nl
P2860
P1476
New β-glucan inhibitors as antifungal drugs.
@en
P2093
Donald E Bierer
Richard F Hector
P2860
P304
P356
10.1517/13543776.2011.603899
P407
P577
2011-07-25T00:00:00Z